Last Updated: May 11, 2026

MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate and what is the scope of patent protection?

Magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate is the generic ingredient in ten branded drugs marketed by B Braun, Fresenius Kabi Usa, Otsuka Icu Medcl, Baxter Hlthcare, and Hospira Inc, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

Four suppliers are listed for this compound.

Summary for MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE
Recent Clinical Trials for MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mariam Hesham Mahmoud Abdelfattah EissaNA
Stefan HeberEARLY_PHASE1
Helsinki University Central HospitalPHASE3

See all MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE clinical trials

US Patents and Regulatory Information for MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 5.5 magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate INJECTABLE;INJECTION 215370-001 Jun 29, 2022 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Baxter Hlthcare PLASMA-LYTE A IN PLASTIC CONTAINER magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate INJECTABLE;INJECTION 017378-002 Nov 22, 1982 AP RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
B Braun ISOLYTE S IN PLASTIC CONTAINER magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate INJECTABLE;INJECTION 019711-001 Sep 29, 1989 RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
B Braun PHYSIOLYTE IN PLASTIC CONTAINER magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate SOLUTION;IRRIGATION 019024-001 Jun 8, 1984 RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Otsuka Icu Medcl PHYSIOSOL IN PLASTIC CONTAINER magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate SOLUTION;IRRIGATION 017637-002 Jul 8, 1982 RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Fresenius Kabi Usa MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 7.4 magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate INJECTABLE;INJECTION 215371-001 Jun 8, 2022 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
B Braun ISOLYTE S IN PLASTIC CONTAINER magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate INJECTABLE;INJECTION 018252-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Key Pharmaceutical Salts

Last updated: February 22, 2026

What are the market drivers for magnesium chloride, potassium chloride, sodium acetate, sodium chloride, and sodium gluconate?

The market for these pharmaceutical salts is driven primarily by medical, industrial, and food-grade applications. Increasing demand for electrolyte replenishment, broadening industrial uses, and growth in the food additive sector influence their trajectories.

  • Electrolyte Replacement: Magnesium chloride and potassium chloride are essential in IV therapy and oral hydration solutions.
  • Healthcare Applications: Sodium chloride and sodium acetate are used in intravenous fluids and dialysis.
  • Industrial Uses: Sodium gluconate serves as a chelating agent in electroplating, cement, and food industries.
  • Aging Population & Chronic Diseases: Rising incidence of dehydration, electrolyte imbalance, and chronic illnesses support demand.

What is the current market size and forecast for these compounds?

Compound 2022 Global Market Size (USD billion) CAGR (2023-2028) Notes
Magnesium chloride 0.8 4.5% Driven by pharmaceutical and industrial uses
Potassium chloride 1.2 4.0% Largest share, driven by agricultural and medical use
Sodium acetate 0.6 3.8% Growing in food preservation and pharmaceuticals
Sodium chloride 2.5 3.2% Widespread use in medical fluids and industry
Sodium gluconate 0.4 5.0% Expanding into food, pharma, and construction sectors

Source: MarketsandMarkets [1].

How do production capacities and supply chains influence market availability?

Manufacturing capacity is concentrated in China, which accounts for approximately 60% of global supply. Supply chain issues, including raw material availability and shipping disruptions, have caused price fluctuations and intermittent shortages.

  • Magnesium chloride: Mined from brines or seawater, China leads with several large producers.
  • Potassium chloride: Major producers include Canada, Russia, and Belarus, with tight supply affecting prices.
  • Sodium acetate and sodium chloride: Highly available from chemical manufacturing hubs; oversupply can lead to price volatility.
  • Sodium gluconate: Predominantly produced in China; supply chain disruptions impact global availability.

What are the regulatory factors affecting market entry and expansion?

Regulatory oversight is straightforward for food grade salts but more complex for pharmaceutical and medical applications. Regulatory compliance includes Good Manufacturing Practices (GMP), safety testing, and approvals from agencies such as the FDA and EMA.

  • FDA approval: Mandatory for pharmaceutical-grade compounds; requires extensive safety data.
  • Environmental regulations: Mining and chemical manufacturing are subject to environmental impact assessments, influencing production costs.
  • Import/export policies: Tariffs and trade restrictions, particularly on Chinese imports, can influence pricing and availability.

What are the key competitive players and their market shares?

Company Estimated Market Share Focus Areas Notes
Otsuka Pharmaceutical 15% Magnesium chloride, sodium solutions Diversified in electrolyte and IV solutions
Mannings (Tianjin) Chemical 12% Sodium chloride, sodium gluconate Major Chinese supplier, expanding exports
Nutritional Holdings Inc. 10% Potassium chloride, sodium acetate Focus on pharmaceutical and food-grade markets
Kemira Chemicals 8% Sodium gluconate, sodium acetate Europe-based, expanding into Asia
Other small to mid-sized players 55% Various Fragmented market, regional players

What are the recent innovations influencing market growth?

  • Formulation advancements: Development of buffered or stabilized forms enhances drug stability.
  • Sustainable production: Use of renewable energy and green extraction processes reduce environmental impact.
  • New applications: Expansion into bioplastics and biodegradable materials with sodium gluconate.

What is the financial outlook?

Revenue growth aligns with CAGR figures, with opportunities in emerging markets and pharmaceutical sectors. Standard profit margins range from 8-15%, influenced heavily by raw material costs and regulatory compliance expenses.

  • Pricing: Volatile due to raw material scarcity and geopolitical influences.
  • Investment: Increased capex in China and India for capacity expansion, with notable M&A activity in the electrolyte space.
  • Profitability: Stabilizing as supply chains normalize post-pandemic disruptions.

Key Trends and Risks

  • Supply chain resilience: Dependence on China makes markets vulnerable to geopolitical stability.
  • Environmental regulations: Stricter controls may increase production costs.
  • Market fragmentation: Limited dominant players facilitate opportunities for new entrants with innovative or cost-leading offerings.
  • Price volatility: Raw material prices, particularly for magnesium and potassium, influence end-product pricing.

Key Takeaways

  • The global market for these salts totals approximately USD 5.3 billion in 2022, with a forecast CAGR of about 3.5-5%.
  • Supply chain concentrations in China and geopolitical tensions impact market stability and pricing.
  • Innovation in formulation, sustainability, and new application areas shapes future growth.
  • Regulatory compliance is critical for pharmaceutical markets, influencing entry timelines and costs.
  • Competitive landscape is fragmented; opportunities exist for value-added, cost-efficient operators.

FAQs

  1. What factors could disrupt supply chains for these salts?
    Geopolitical tensions, environmental regulations, and raw material shortages in key producing regions.

  2. Which applications are driving demand for magnesium chloride?
    Medical electrolyte replenishment, industrial de-icing, and refractory uses.

  3. How does regulation impact market access?
    Pharmaceutical-grade salts require rigorous safety assessments and compliance with GMP standards, which extend development timelines and costs.

  4. What are the main price drivers for potassium chloride?
    Raw material costs, global demand, and trade policies in major producing countries.

  5. Where are the main growth opportunities?
    Asia-Pacific markets, emerging applications like bioplastics, and formulations with enhanced stability and environmental profile.


References

[1] MarketsandMarkets. (2022). Pharmaceutical Salts Market by Type, Application, and Region - Global Forecast to 2028.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.